Several reports and surveys of the perception of red biotechnology uses conducted in recent years show the complexity of European’s attitude to innovative therapies which might be used in medicine. Polish people, as well as the rest of European nations in general, support the development of gene therapy or pharmacogenetics, whereas the issues of stem cells research and uses of genetic information are still under discussion. The results of various questionnaires prove that a rise of the optimism level in this matter is necessary. It occurred that in order to build public acceptability and confidence in biotechnology policy, it is crucial to ensure the society that moral and ethical aspects are taken into consideration.
Operational Program Digital Poland, 2014-2020, Measure 2.3: Digital accessibility and usefulness of public sector information; funds from the European Regional Development Fund and national co-financing from the state budget.
Feb 18, 2020
Dec 6, 2019
|Odbiór społeczny innowacyjnych terapii i biofarmaceutyków w Polsce i Europie||Feb 18, 2020|
Ziółkowski, Piotr Babula- Skowrońska, Danuta Kaczmarek, Małgorzata Cieśla, Agata Sadowski, Jan
Nowak, Jacek K.
Krzymiński, Paweł Długońska, Henryka
Złotkowska, Hanna Czakaj, Joanna Krakowiak, Andrzej
Michalik, Joanna Zwierzchowski, Lech Strokovskaya, Ludmila Szołajska, Ewa